New offerings apply immersive conversational research and AI-accelerated techniques to established pharma research needs
CHICAGO, Sept. 9, 2026 /PRNewswire/ — Reach3 Insights, a full-service insights consultancy specializing in AI-accelerated conversational research, today announced three new pharma-focused solutions for Awareness, Trial & Usage (ATU), patient journey and communications research.
The solutions apply Reach3’s mobile-first conversational research techniques to established pharma studies, combining predictive quantitative measures with seamless open-ended feedback, photos and video in one unified research experience. AI-powered moderation and probing drives additional depth from participants, while text message-based notifications allow researchers to both quickly follow up with patients and health care professionals and/or capture feedback closer to an experience.
The three solutions include:
- ATU: Supports brands before and after launch, going beyond measures of awareness, trial and usage to examine the perceptions, experiences and behaviors that shape awareness, adoption and ongoing usage.
- Patient journey: Maps the path to care using patients’ own words, images and video to identify the moments, barriers and experiences that affect what happens along the way.
- Communications: Tests messages and campaigns with qualitative depth and quantitative scale in one research experience, showing what breaks through & resonates with patients and HCPs and why.
Reach3 applies its mobile-first conversational research methods to health and pharma studies including capturing patient experiences from symptom onset through treatment, collecting feedback triggered by medical device interactions and conducting ongoing research with health care audiences.
“Some of the most useful context comes from hearing patients and HCPs describe an experience in their own words,” said Amr Solouha, healthcare practice lead at Reach3 Insights. “Across ATU, patient journey and communications research, we can combine that feedback with quantitative measures to better understand the behaviors and perceptions showing up in the data.”
Reach3 will share examples of the three solutions during The Modern Pharma Insights Playbook: Re-imagining ATU, Patient Journeys & Comms Testing in the AI Era, a one-hour webinar featuring Novartis on Sept. 10 at 2 p.m. EDT. The session will explore case studies and approaches for applying in-the-moment qual, quant and video research to ATU, patient journey and communications research.
About Reach3 Insights
Reach3 Insights is an award-winning, full-service strategic insights consultancy helping leading brands uncover deeper truths and turn human understanding into business impact. Combining industry expertise with AI-driven conversational research methodologies, Reach3 captures the context, emotions and motivations behind consumer behavior for brands like Novartis, Coca-Cola, Warner Bros. Discovery, PayPal, Samsung and Mars. Through agile research design and story-driven activation, Reach3 delivers richer, more authentic insights that inspire confident decisions and measurable growth. Part of Rival Group, Reach3 was recognized as a Top 5 most innovative full-service agency in Greenbook’s 2025 GRIT report. reach3insights.com
Media contact:
Marie Melsheimer
422246@email4pr.com
+1-541-815-3951
View original content to download multimedia:https://www.prnewswire.com/news-releases/reach3-insights-introduces-new-pharma-focused-solutions-for-atu-patient-journey-and-communications-research-302873759.html
SOURCE Reach3 Insights
